NCT07227155 (HOPE Resource) is a clinical trial in Aplastic Anemias, sponsored by Medical College of Wisconsin.

Who is sponsoring NCT07227155?

NCT07227155 is sponsored by Medical College of Wisconsin.

What condition does NCT07227155 study?

NCT07227155 studies Aplastic Anemias, Hemoglobinopathies, Bone Marrow Failure.

Is NCT07227155 still recruiting?

NCT07227155 is currently not yet recruiting. Last updated 29 January 2026.

Last reviewed 2026-01-29 · How we verify

NCT07227155: HOPE Resource

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The HOPE Biobank Resource (BMT CTN 2402 HOPE)

Not yet recruiting Last updated 29 January 2026

What this trial tests

trial in Aplastic Anemias in 375 participants. Not yet recruiting.

Timeline

27 March 2026

Primary endpoint
30 March 2031

30 March 2031

Quick facts

Lead sponsor	Medical College of Wisconsin
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	375
Start date	27 March 2026
Primary completion	30 March 2031
Estimated completion	30 March 2031

Conditions studied

Aplastic Anemias — all drugs for Aplastic Anemias →
Hemoglobinopathies — all drugs for Hemoglobinopathies →
Bone Marrow Failure — all drugs for Bone Marrow Failure →

Sponsor

Medical College of Wisconsin

Who can join

Eligibility, any sex, with Aplastic Anemias or Hemoglobinopathies. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective, multicenter study that will establish a repository of biospecimens and clinical data from patients undergoing hematopoietic stem cell transplant (HCT) or gene therapy (GT) for treatment of non-malignant blood diseases.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Medical College of Wisconsin trials

Trials by the same sponsor.

NCT07260552 — Rapid Engagement for Solutions to Population and Outcomes Through Networked Dialogue for Coronary Heart Disease · not yet recruiting
NCT06795360 — Weight Changes After Incretin-mimetics · NA · not yet recruiting
NCT07228208 — Role of Endothelial Dysfunction on Exercise Pressor Reflex in Type 2 Diabetes · NA · not yet recruiting
NCT07298460 — Stimulation-based Therapy to Improve Balance in DCM · Phase 1, PHASE2 · not yet recruiting
NCT07434544 — Cardiometabolic Effects of Non-Nutritive Sweeteners (NNS) in Type 1 Diabetes (T1D) · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07227155 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical College of Wisconsin
Last refreshed: 29 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07227155.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing